Jan 6, 2020   SOURCE: PR NewsWire

BioMarin to Present at 38th Annual J.P. Morgan Healthcare Conference in San Francisco

SAN RAFAEL, Calif., Jan. 6, 2020 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer, will participate in the 38(th) Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2020 at 7:30 am PT, or 10:30 am ET, in San Francisco, California. To access the live webcast, please visit the investor section of the BioMarin website, www.biomarin.com. A replay will also be archived on the site for at least one week following the event.

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of seven commercialized products and multiple clinical and pre-clinical product candidates.

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.


     Contacts:





     Investors                              
     Media


                Traci McCarty                
     
         Debra Charlesworth


                BioMarin Pharmaceutical Inc.         BioMarin Pharmaceutical Inc.


                (415) 455-7558               
     
         (415) 455-7451

View original content to download multimedia:http://www.prnewswire.com/news-releases/biomarin-to-present-at-38th-annual-jp-morgan-healthcare-conference-in-san-francisco-300978584.html

SOURCE BioMarin Pharmaceutical Inc.